Pre-ANDA Interactions with the FDA (6of16) Generic Drugs Forum 2020

Kris Andre from CDER’s Office of Generic Drugs shares how to interact with FDA prior to submission on complex products. She discusses suggestions and best practices.

_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Phone: [phone] I [phone]